Diagnostic utility of fusion 18F-fluorodeoxyglucose positron emission tomography/cardiac magnetic resonance imaging in cardiac sarcoidosis

被引:0
作者
Mana Okune
Masakazu Yasuda
Naoko Soejima
Yoshinori Kagioka
Kazuyoshi Kakehi
Takayuki Kawamura
Kohei Hanaoka
Hayato Kaida
Kazunari Ishii
Gaku Nakazawa
Shunichi Miyazaki
Yoshitaka Iwanaga
机构
[1] Kindai University Faculty of Medicine,Division of Cardiology, Department of Internal Medicine
[2] Osaka Pref. Saiseikai Tondabayashi Hospital,Division of Cardiology
[3] Kindai University,Division of Positron Emission Tomography, Institute of Advanced Clinical Medicine
[4] Kindai University Faculty of Medicine,Departments of Radiology
[5] National Cerebral and Cardiovascular Center,Center for Cerebral and Cardiovascular Disease Information
来源
Journal of Nuclear Cardiology | 2022年 / 29卷
关键词
Cardiac sarcoidosis; cardiac magnetic resonance; fusion imaging; positron emission tomography;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:753 / 764
页数:11
相关论文
共 159 条
[1]  
Kandolin R(2015)Cardiac sarcoidosis: Epidemiology, characteristics, and outcome over 25 years in a nationwide study Circulation 131 624-632
[2]  
Lehtonen J(2005)A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy Am Heart J 150 459-463
[3]  
Airaksinen J(2014)HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis Heart Rhythm 11 1305-1323
[4]  
Vihinen T(2019)JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis-digest version Circ J 83 2329-2388
[5]  
Miettinen H(2005)Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis J Am Coll Cardiol 45 1683-1690
[6]  
Ylitalo K(2013)CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis JACC Cardiovasc Imaging 6 501-511
[7]  
Ardehali H(2016)Risk stratification for major adverse cardiac events and ventricular tachyarrhythmias by cardiac MRI in patients with cardiac sarcoidosis Open Heart 3 e000437-998
[8]  
Howard DL(2020)Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: Analysis by cardiac magnetic resonance imaging Clin Res Cardiol 109 988-248
[9]  
Hariri A(2012)The use of J Nucl Med 53 241-336
[10]  
Qasim A(2014)F-FDG PET in the diagnosis of cardiac sarcoidosis: A systematic review and metaanalysis including the Ontario experience J Am Coll Cardiol 63 329-767